APA (7th ed.) Citation

Sylvie Pichon, Francoise Guinet-Morlot, Jamshid Saleh, Brandon Essink, Andrea-Clemencia, Annick Moureau, . . . Ada-Maria Minutello. (2023). Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Sylvie Pichon, Francoise Guinet-Morlot, Jamshid Saleh, Brandon Essink, Andrea-Clemencia, Annick Moureau, Celine Petit, and Ada-Maria Minutello. Safety and Immunogenicity of Three Dose Levels of an Investigational, Highly Purified Vero Cell Rabies Vaccine: A Randomized, Controlled, Observer-blinded, Phase II Study with a Simulated Post-exposure Regimen in Healthy Adults. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Sylvie Pichon, et al. Safety and Immunogenicity of Three Dose Levels of an Investigational, Highly Purified Vero Cell Rabies Vaccine: A Randomized, Controlled, Observer-blinded, Phase II Study with a Simulated Post-exposure Regimen in Healthy Adults. Taylor & Francis Group, 2023.